Integra LifeSciences, has announced the completion of patient enrollment in a pivotal clinical trial designed to assess the safety and effectiveness of Integra dermal regeneration template in the treatment of diabetic foot ulcers. Integra ...
NeuroMetrix, a medical device company, and Omron Medical Devices, a subsidiary of Omron Healthcare China, have entered into an agreement for the distribution of NC-stat DPNCheck in China. Pursuant to the terms of the agreement, ...
Tags: Medical Devices, Medicine
California-based medical device Harbor MedTech has gained FDA marketing approval for its first product, Architect, an advanced collagen matrix for treatment of partial and full thickness skin wounds. Harbor president and founder Jerry ...
Advanced wound care technology company EO2 Concepts has introduced a new dressing for the treatment of difficult-to-heal wounds. Designed to complement and enhance the company's TransCu O2 tissue oxygenation system, OxySpurOxygen ...
Specialty pharmaceutical company ULURU has introduced Altrazeal in a 0.75gm blister pack targeting US chronic wound market. New packaging system provides information regarding appropriate quantity for the treatment of chronic wounds and ...
Tags: ULURU, blister pack, pharmaceutical company
ConvaTec, a developer of new medical technologies, has inaugurated a new office at the World Trade Center in Bangalore, India. The new facility, which will serve as headquarters for the company's Indian operations, will offer hospitals ...
Tags: medical technologies, medical, Convatec, healthcare, New Office
MiMedx Group has reported positive results from a study of its EpiFix, a dehydrated human amniotic membrane allograft, designed as a treatment for diabetic neurovascular foot ulcers. The controlled, randomized trial, which enrolled 80 ...
Tags: MiMedx Group, EpiFix, dehydrated human amniotic membrane allograft
Pharmaceutical company in the US, ULURU has completed the initial production of the Altrazeal 0.75g transparent blister pack. The Altrazeal 0.75g blister pack, which completed test marketing in the US and Europe, incorporates an ...
Tags: ULURU, CEO, smaller chronic wounds
Spiracur, a developer of non-powered negative pressure wound therapy solutions, has launched new SNaP bridge wound care dressing. SNaP bridge dressing when combined with a protective boot offloading device can be used for the ...
Tags: wound care dressing, clinical product, clinical technology
Uluru said that the first shipment of Altrazeal has been received by its marketing partner in Australia. Altrazeal, a wound treatment technology, has shown clinical and economic advantages in a number of chronic and acute wounds, which ...
Tags: Altrazeal, wound treatment technology, marketing partner
Royer Biomedical(RBI)wins FDA approval to progress human testing of AppliGel-G(Gentamicin)in management of diabetic foot ulcers(DFU). The patented proprietary dissolvable non-immunogenic polymer drug delivery system platform has ...
Cardium Therapeutics and its Tissue Repair Company, Cardium, will utilize AMRI's Burlington, US, site to manufacture sterile pre-filled syringes in support of the US introduction of Excellagen, as per the signed contract agreement. ...
Tags: Cardium Therapeutics, syringe-based, pre-filled syringes
Avita Medical has initiated an European clinical study of its ReCell Spray-On Skin device, designed for treating venous leg ulcers. Designed for use in burns, plastic, reconstructive and cosmetic procedures, the device uses the company's ...
HAVANA, Cuba (ACN) -- The Brazilian Ministry of Development, Industry and Foreign Trade will grant a $220 million credit to Fanavid SA to build a glass factory in Cuba, Hipolito Rocha announced. Rocha, general director of the Brazilian ...
Tags: market view, glass